NCT05710328 2026-03-02
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial
Eastern Cooperative Oncology Group
Phase 2 Active not recruiting
Clinical Trials
1 trialsActive not recruiting × Anatomic Stage II Breast Cancer AJCC v8 × Fluorodeoxyglucose F18 × Clear all